(Source: ASMBS, 2025) The researchers own conclusion is worth stating plainly: GLP-1 patients may need to adjust their expectations, adhere more closely to treatment, or opt for metabolic and bariatric surgery to achieve desired results. This isnt a case against GLP-1 therapy its a case for the structured, physician-supervised adherence support that determines whether patients get the results the clinical trials show are possible
When Patients Choose Continuous Treatment Versus Breaks Some patients view GLP-1 therapy as a permanent lifestyle medicationsimilar to how someone might take a blood pressure medication indefinitely
Jardiance family Disease area(s): Metabolic/cardiovascular Manufacturer(s): Boehringer Ingelheim/Eli Lilly and Company 2024 Sales (USD): $12.38 billion Why it sold so well: Co-developed by Boehringer Ingelheim and Eli Lilly, the Jardiance family experienced robust growth in 2024, driven by expanding clinical indications and strong global demand
By inhibiting this enzyme, Glutathione helps to reduce the production of melanin, leading to a lighter, brighter skin tone and a more uniform complexion
Long-term data is still evolving, particularly as these medications are used more widely outside of diabetes care
They work gradually in your system, with most people starting on a lower dose that may be increased over time depending on how well you respond and any side effects you experience